QA: Neos Therapeutics Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001467652_2017_Neos_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001467652')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001467652, Neos Therapeutics Inc.

  xvar xval
0 AssetsCurrent 55,269,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,076,000
3 remainder_Assets 17,797,000
4 LiabilitiesCurrent 21,645,000
5 LiabilitiesNoncurrent 60,045,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 11,437,000
8 SellingGeneralAndAdministrativeExpense 12,625,000
9 ResearchAndDevelopmentExpense 12,207,000
10 remainder_Expenses 49,309,000
11 remainder_Revenues 9,154,000
12 remainder_NetIncome -6,909,000
13 remainder_ComprehensiveNetIncome -1,000
  yvar yval
0 Assets 80,142,000
1 Liabilities 81,690,000
2 Expenses 85,578,000
3 Revenues 9,154,000
4 StockholdersEquity -1,548,000
5 NetIncome -83,333,000
6 ComprehensiveNetIncome -83,333,500
7 BaseVar 131,737,000
8 EconomicCapitalRatio -1.06

Edgar->Model Mapping

Feature Distribution